Open AccessNational Underutilization of Neoadjuvant Chemotherapy for Gastric Cancer
Author(s) -
Natalie Liu,
YiWei Xu,
Amir A. RahnemaiAzar,
Daniel E. Abbott,
Sharon M. Weber,
Anne O. Lidor
Publication year - 2019
Publication title -
journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.168
H-Index - 126
eISSN - 1873-4626
pISSN - 1091-255X
DOI - 10.1007/s11605-019-04439-y
Subject(s) - medicine , cancer , chemotherapy , neoadjuvant therapy , stage (stratigraphy) , gastrectomy , oncology , breast cancer , surgery , paleontology , biology
Since the publication of the landmark MAGIC trial in 2006, neoadjuvant chemotherapy has become the standard of care for stage II/III gastric cancer. Nevertheless, many patients still do not begin their treatment with neoadjuvant chemotherapy. The objective of our study was to identify factors associated with underutilization of neoadjuvant chemotherapy for stage II/III gastric cancer.